Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's offer "significantly undervalues" the company.Auxilium did not reject the offer outright and said it maintained the right to engage in discussions with Endo.Endo made an unsolicited bid last week to purchase Auxilium for about $2.2 billion.Auxilium's board determined that Endo's offer is not a superior proposal under the terms of its existing merger agreement with Canadian eye drug maker QLT Inc.
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. Shares of AUXL traded higher by 0.06% or $0.02/share to $31.14. In the past year, the shares have traded as low as $16.36 and as high as $32.89. On average, 1566920 shares of AUXL exchange hands on a given day and today's volume is recorded at 3221671.
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLT traded higher by 0.35% or $0.02/share to $5.74. In the past year, the shares have traded as low as $4.33 and as high as $7.90. On average, 5316 shares of QLT.TO exchange hands on a given day and today's volume is recorded at 1791.
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLTI fell by 0.19% or $-0.01/share to $5.20. In the past year, the shares have traded as low as $4.16 and as high as $7.10. On average, 205030 shares of QLTI exchange hands on a given day and today's volume is recorded at 193482.
Source
